Show simple item record

dc.contributor.authorGarrido, Pilar
dc.contributor.authorAldaz, Azucena
dc.contributor.authorVera, Ruth
dc.contributor.authorCalleja, Miguel Ángel
dc.contributor.authorÁlava, Enrique de
dc.contributor.authorMartín, Miguel
dc.contributor.authorMatias-Guiu, Xavier
dc.contributor.authorPalacios, José
dc.date.accessioned2021-04-20T09:03:14Z
dc.date.available2021-04-20T09:03:14Z
dc.date.issued2018
dc.identifier.issn1699-3055
dc.identifier.urihttp://hdl.handle.net/10459.1/71070
dc.description.abstractPrecision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person. Precision medicine is transforming clinical and biomedical research, as well as health care itself from a conceptual, as well as a methodological viewpoint, pro viding extraordinary opportunities to improve public health and lower the costs of the healthcare system. However, the implementation of precision medicine poses ethical–legal, regulatory, organizational, and knowledge-related challenges. Without a national strategy, precision medicine, which will be implemented one way or another, could take place without the appropriate planning that can guarantee technical quality, equal access of all citizens to the best practices, violating the rights of patients and professionals, and jeopardizing the solvency of the healthcare system. With this paper from the Spanish Societies of Medical Oncology, Pathology, and Hospital Pharmacy, we highlight the need to institute a consensual national strategy for the development of precision medicine in our country, review the national and international context, comment on the opportunities and challenges for implementing precision medicine, and outline the objectives of a national strategy on precision medicine in cancer.ca_ES
dc.language.isoengca_ES
dc.publisherSpringerca_ES
dc.relation.isformatofReproducció del document publicat a https://doi.org/10.1007/s12094-017-1740-0ca_ES
dc.relation.ispartofClinical & Translational Oncology, 2018, vol. 20, núm. 4, p. 443-447ca_ES
dc.rightscc-by (c) Garrido et al. 2018ca_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectOncologyca_ES
dc.subjectPrecision medicineca_ES
dc.subjectConsensusca_ES
dc.titleProposal for the creation of a national strategy for precisionmedicine in cancer: a position statement of SEOM, SEAP,and SEFHca_ES
dc.typeinfo:eu-repo/semantics/articleca_ES
dc.type.versioninfo:eu-repo/semantics/publishedVersionca_ES
dc.rights.accessRightsinfo:eu-repo/semantics/openAccessca_ES
dc.identifier.doihttps://doi.org/10.1007/s12094-017-1740-0


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

cc-by (c) Garrido et al. 2018
Except where otherwise noted, this item's license is described as cc-by (c) Garrido et al. 2018